Increased production of macrophage migration inhibitory factor by PBMCs of atopic dermatitis

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 3 II, 1999, Pages 659-664

  Shimizu, Tadamichi ^a   Abe, Riichiro ^a   Ohkawara, Akira ^a   Nishihira, Jun ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; Chronic urticaria; Concanavalin A; Cytokine; Macrophage migration inhibitory factor; PBMCs

Indexed keywords

CONCANAVALIN A; CYTOKINE; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; STEROID;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; CELL MIGRATION; CHRONIC URTICARIA; CLINICAL ARTICLE; DERMATITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; INFLAMMATORY DISEASE; MACROPHAGE; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; CELLS, CULTURED; DERMATITIS, ATOPIC; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED;

EID: 0032872026     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(99)70339-8     Document Type: Article

References (33)

1. Sustiel A, Rocklin R. T cell responses in allergic rhinitis, asthma and atopic dermatitis. Clin Exp Allergy 1989;19:11-8.
2. Kapp A. Atopic dermatitis: the skin manifestation of atopy. Clin Exp Allergy 1995;25:210-9.
3. Thestrup-Pedersen K. Atopic dermatitis. In: Bos JD, editor. Skin immune system (SIS). 2nd ed. New York: CRC Press; 1997. p 497-507.
4. Zachary CB, Allen MH, MacDonald DM. In situ quantitation of T-lymphocyte subsets and Langerhans cells in the inflammatory infiltrate of atopic eczema. Br J Dermatol 1985;112:149-56.
5. Lever R, Turbitt M, Sanderson A, Mackie R. Immunophenotyping of the cutaneous infiltrate and the mononuclear cells in the peripheral blood in patients with atopic dermatitis. J Invest Dermatol 1987;89:4-7.
6. Holden CA. Atopic dermatitis-messengers, second messengers and cytokines. Clin Exp Dermatol 1993;18:201-7.
7. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994;102:128-38.
8. Bloom BR, Bennett B. Mechanism of reaction in vivo associated with delayed-type hypersensitivity. Science 1966;153:80-2.
9. Weiser WY, Temple PA, Witek-Giannoti JS, Remold HG, Clark SC, David JR. Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc Natl Acad Sci U S A 1989;86:7522-6.
10. Bernhagen J, Bacher M, Calandra T, Metz CN, Doty SB, Donnelly T, et al. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med 1996;183:277-82.
11. Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994;179:1895-902.
12. Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A 1996;93:7849-54.
13. Donnelly SC, Haslett C, Reid PT, Grant IS, Wallace WA, Metz CN, et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 1997;3:320-3.
14. Rossi AG, Haslett C, Hirani N, Greening AP, Rahman I, Metz CN, et al. Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF): potential role in asthma. J Clin Invest 1998;15:2869-74.
15. Shimizu T, Ohkawara A, Nishihira J, Sakamoto W. Identification of macrophage migration inhibitory factor (MIF) in human skin and its immunohistochemical localization. FEBS Lett 1996;381:188-202.
16. Shimizu T, Abe R, Ohkawara A, Mizue Y, Nishihira J. Macrophage migration inhibitory factor is an essential immunoregulatory cytokine in atopic dermatitis. Biochem Biophys Res Commun 1997;240:173-8.
17. Lanahan A, Williams JB, Sanders LK, Nathans D. Growth factor-induced delayed early response genes. Mol Cell Biol 1992;12:3919-29.
18. Sakai M, Nishihira J, Hibiya Y, Koyama Y, Nishi S. Glutathione binding rat liver 13k protein is the homologue of the macrophage migration inhibitory factor. Biochem Mol Biol Int 1994;33:439-46.
19. Bacher M, Meinhardt A, Lan HY Mu W, Mets CN, Chesney JA, et al. Macrophage migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol 1997;150:235-46.
20. Bucala R. MIF rediscovered: cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response. FASEB J 1996;10:1607-13.
21. Nishihira J. Novel pathophysiological aspects of macrophage migration inhibitory factor. Int J Mol Med 1998;2:17-28.
22. Hanifin JM, RajkaG. Diagnostic features of atopic dermatitis. Acta Derm Venerol (Stockh) 1980;92(Suppl):44-7.
23. Bahmer FA, Schafer J, Shubert HJ. Quantitation of the extent and the severity of atopic dermatitis: the ADASI score. Arch Dermatol 1991;127:1239-40.
24. Katagiri K, Itami S, Hatano Y, Takayasu S. Increased levels of IL-13 mRNA, but not IL-4 mRNA, are found in vivo in peripheral blood mononuclear cells (PBMC) of patients with atopic dermatitis (AD). Clin Exp Immunol 1997;108:289-94.
25. Rajka G. Essential aspects of atopic dermatitis. New York: Springer Verlag; 1989.
26. Leung DYM, Geha RS. Immunoregulatory abnormalities in atopic dermatitis. Clin Rev Allergy 1986;4:67-86.
27. Herz U, Bunikowski R, Renz H. Role of T cells in atopic dermatitis. Int Arch Allergy Immunol 1998;115:179-90.
28. Soter NA. Morphology of atopic eczema. Allergy 1989;9:16-9.
29. Elliot ST, Hanifin JM. Delayed cutaneous hypersensitivity and lymphocyte transformation: dissociation in atopic dermatitis. Arch Dermatol 1979;115:36-9.
30. Ohmen J, Hanifin JM, Nickoloff BJ, Rea TH, Wyzykowski R, Kim J, et al. Overexpression of IL-10 in atopic dermatitis: contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 1996;154:1956-63.
31. Goodyear HM, Watson PJ, Egan SA, Price EH, Kenny PA, Harper JI. Skin microflora of atopic eczema in first time hospital attenders. Clin Exp Dermatol 1993;18:300-4.
32. Calandra T, Spiegel LA, Metz CN, Bucala R. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of gram-positive bacteria. Proc Natl Acad Sci USA 1998;95:11383-8.
33. Shimizu T, Abe R, Ohkawara A, Nishihira J. Ultraviolet B radiation upregulates the production of macrophage migration inhibitory factor (MIF) in human epidermal keratinocytes. J Invest Dermatol 1999;112:210-5.